Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1B | P47901 | 10/20 | 0.43 |
| ▸ | PDE3B | Q13370 | 6/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 6/20 | 0.42 |
| ▸ | P2RY12 | Q9H244 | 5/20 | 0.42 |
| ▸ | PDE2A | O00408 | 2/20 | 0.41 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2331979 | 0.97 | AVPR1B (0.44) | AVPR1BPDE3BPDE3AP2RY12AR | |
| SCHEMBL2327135 | 0.94 | PDE3B (0.46) | AVPR1BPDE3BPDE3AP2RY12PDE2A | |
| SCHEMBL2324281 | 0.93 | PDE3B (0.43) | AVPR1BPDE3BPDE3AP2RY12AR | |
| SCHEMBL2323141 | 0.90 | PDE3B (0.46) | AVPR1BPDE3BPDE3AP2RY12PDE2A | |
| SCHEMBL2329630 | 0.89 | AR (0.46) | PDE3BPDE3AP2RY12ARHDAC1 | |
| SCHEMBL2323506 | 0.89 | PDE3B (0.47) | PDE3BPDE3AP2RY12PDE2AAR | |
| SCHEMBL2323759 | 0.89 | PDE3B (0.47) | PDE3BPDE3AP2RY12PDE2AAR | |
| SCHEMBL2329243 | 0.89 | PDE3B (0.44) | PDE3BPDE3AP2RY12ARHDAC1 | |
| SCHEMBL2326861 | 0.89 | PDE3B (0.44) | PDE3BPDE3AP2RY12LTB4RAR | |
| SCHEMBL2322948 | 0.88 | PDE3B (0.48) | PDE3BPDE3AP2RY12PDE2AAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1246808-A1 | 1,2-DIARYL BENZIMIDAZOLES FOR TREATING ILLNESSES ASSOCIATED WITH A MICROGLIA ACTIVATION | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-10-09 | — | — | EP | disclosed |
| WO-2001051473-A1 | 1,2-DIARYL BENZIMIDAZOLES FOR TREATING ILLNESSES ASSOCIATED WITH A MICROGLIA ACTIVATION | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-07-19 | — | — | WO | disclosed |